NIVALIS THERAPEUTICS, INC. INDEMNIFICATION AGREEMENTIndemnification Agreement • May 13th, 2015 • Nivalis Therapeutics, Inc. • Pharmaceutical preparations • Delaware
This Indemnification Agreement (“Agreement”) is made as of [ ], 20[ ] by and between NIVALIS THERAPEUTICS, INC., a Delaware corporation (the “Company”), and [ ] (“Indemnitee”).
EMPLOYMENT AGREEMENTEmployment Agreement • May 13th, 2015 • Nivalis Therapeutics, Inc. • Pharmaceutical preparations • Colorado
THIS EMPLOYMENT AGREEMENT (this “Agreement”), effective as of January 21, 2015, is between N30 Pharmaceuticals, Inc., a Delaware corporation (the “Company”), and R. Michael Carruthers (“Employee”).
ContractWarrant Agreement • May 13th, 2015 • Nivalis Therapeutics, Inc. • Pharmaceutical preparations • Delaware
THIS WARRANT HAS NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED OR ANY STATE SECURITIES LAWS. NO SALE OR DISPOSITION MAY BE EFFECTED WITHOUT (i) EFFECTIVE REGISTRATION STATEMENTS RELATED THERETO, (ii) AN OPINION OF COUNSEL OR OTHER EVIDENCE, REASONABLY SATISFACTORY TO THE COMPANY, THAT SUCH REGISTRATIONS ARE NOT REQUIRED, (iii) RECEIPT OF NO-ACTION LETTERS FROM THE APPROPRIATE GOVERNMENTAL AUTHORITIES, OR (iv) OTHERWISE COMPLYING WITH THE PROVISIONS OF SECTION 7 OF THIS WARRANT.
AMENDMENT to the EMPLOYMENT AGREEMENT Effective November 1, 2012 between Nivalis Therapeutics, Inc. (formerly known as N30 Pharmaceuticals, Inc.) and Janice M. Troha (“Employee”)Employment Agreement • May 13th, 2015 • Nivalis Therapeutics, Inc. • Pharmaceutical preparations
WHEREAS, Nivalis Therapeutics, Inc. (formerly known as N30 Pharmaceuticals, Inc. (“Company”)) and the Employee entered into an employment agreement (the “Agreement”) effective as of November 1, 2012;
EMPLOYMENT AGREEMENTEmployment Agreement • May 13th, 2015 • Nivalis Therapeutics, Inc. • Pharmaceutical preparations • Colorado
THIS EMPLOYMENT AGREEMENT (this “Agreement”), effective as of November 1, 2012, is between N30 Pharmaceuticals, Inc., a Delaware corporation (the “Company”), and Janice M. Troha (“Employee”).
AMENDMENT TO EMPLOYMENT AGREEMENTEmployment Agreement • May 13th, 2015 • Nivalis Therapeutics, Inc. • Pharmaceutical preparations • Colorado
This Amendment to Employment Agreement (this “Amendment”) is made and entered into as of December 15, 2014 by and between N30 Pharmaceuticals, Inc., a Delaware corporation (the “Company”), and Sherif Gabriel (“Employee”) and amends that certain Employment Agreement between the Company and Employee dated November 1, 2012 (the “Employment Agreement”).
N30 PHARMACEUTICALS, INC. STOCK OPTION AGREEMENTStock Option Agreement • May 13th, 2015 • Nivalis Therapeutics, Inc. • Pharmaceutical preparations • Delaware
N30 Pharmaceuticals, Inc. (the “Company”) hereby grants to the Grantee listed below (the “Grantee”) an option (the “Option”) to purchase the number shares of Common Stock (“Stock”) of the Company set forth below, subject to the terms and conditions of the Plan and this Stock Option Agreement (the “Option Agreement”) including the Exhibits attached hereto, as follows:
SECOND AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENTInvestor Rights Agreement • May 13th, 2015 • Nivalis Therapeutics, Inc. • Pharmaceutical preparations • New York
THIS SECOND AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT (this “Agreement”) is made as of November 18, 2014, by and among N30 Pharmaceuticals, Inc., a Delaware corporation (the “Company”), and each of the holders of capital stock of the Company listed on Schedule A hereto (each a “Stockholder” and together the “Stockholders”).
AMENDMENT to the EMPLOYMENT AGREEMENT between Nivalis Therapeutics, Inc. (formerly known as N30 Pharmaceuticals, Inc.) and Jon Congleton (“Employee”)Employment Agreement • May 13th, 2015 • Nivalis Therapeutics, Inc. • Pharmaceutical preparations
WHEREAS, Nivalis Therapeutics, Inc. (formerly known as N30 Pharmaceuticals, Inc. (the “Company”)) and the Employee entered into an employment agreement (the “Agreement”) effective as of January 1, 2015;
FIRST AMENDMENT TO LEASELease • May 13th, 2015 • Nivalis Therapeutics, Inc. • Pharmaceutical preparations • Colorado
THIS FIRST AMENDMENT TO LEASE (this “Amendment”) is made effective as of the 5th day of December, 2014, by and between AWEIDA PROPERTIES, INC., a Colorado corporation (“Landlord”), and N30 PHARMACEUTICALS, INC. a Delaware Corporation (“Tenant”) to that certain lease dated March 11, 2010 by and between Landlord and Tenant (the “Lease”). Capitalized terms used herein which are defined in the Lease shall have the meanings therein stated.
EMPLOYMENT AGREEMENTEmployment Agreement • May 13th, 2015 • Nivalis Therapeutics, Inc. • Pharmaceutical preparations • Colorado
THIS EMPLOYMENT AGREEMENT (this “Agreement”), effective as of August 7, 2013, is between N30 Pharmaceuticals, Inc., a Delaware corporation (the “Company”), and Charles H. Scoggin (“Employee”).
SECOND AMENDMENT TO LEASELease • May 13th, 2015 • Nivalis Therapeutics, Inc. • Pharmaceutical preparations
THIS SECOND AMENDMENT TO LEASE (this “Amendment”) is made effective as of the Eleventh day of February, 2015, by and between AWEIDA PROPERTIES, INC., a Colorado corporation (“Landlord”), and N30 PHARMACEUTICALS, INC. a Delaware Corporation (formerly, and identified in the Lease as, a Delaware Limited Liability Company) (“Tenant”) to that certain lease dated March 11, 2010 by and between Landlord and Tenant (the “Lease”), as amended by that certain First Amendment to Lease dated December 5, 2014, for the lease of Premises located at 3122 Sterling Circle, Suite 200, Boulder, Colorado 80301. Capitalized terms used herein which are defined in the Lease shall have the meanings therein stated.
LEASELease • May 13th, 2015 • Nivalis Therapeutics, Inc. • Pharmaceutical preparations • Colorado
